Skip to main content
PLOS One logoLink to PLOS One
. 2023 Feb 14;18(2):e0279781. doi: 10.1371/journal.pone.0279781

Pregnant women and male partner perspectives of secondary distribution of HIV self-testing kits in Uganda: A qualitative study

Michelle A Bulterys 1,2,*, Brienna Naughton 2, Andrew Mujugira 2,3, Jackson Mugisha 3, Agnes Nakyanzi 3, Faith Naddunga 3, Jade Boyer 2, Norma Ware 4, Connie Celum 2, Monisha Sharma 1,2
Editor: Joel Msafiri Francis5
PMCID: PMC9928124  PMID: 36787299

Abstract

Background

HIV self-testing (HIVST) is a promising strategy to increase awareness of HIV status among sub-Saharan African (SSA) men. Understanding user perspectives on HIVST secondary distribution from pregnant women attending antenatal care (ANC) to their male partners is crucial to optimizing delivery strategies.

Methods

We sampled pregnant women attending ANC without their partners and purposively oversampled pregnant women living with HIV (PWHIV) to understand their unique views. We recruited male partners after obtaining contact information from women. We conducted 14 focus group discussions and 10 in-depth interviews with men and pregnant women. We assessed acceptability of HIVST secondary distribution, barriers, facilitators, and interventions to increase HIVST uptake.

Results

Participants felt that HIVST secondary distribution was acceptable, particularly for women in stable relationships. However, many expressed concerns about accusations of mistrust, relationship dissolution, fear of discovering serodifference, and lack of counseling associated with HIVST. PWHIV reported hesitation about secondary distribution, citing fears of unintended HIV status disclosure and abandonment resulting in financial hardship for themselves and their infant. Some participants preferred that providers contact men directly to offer HIVST kits instead of distribution via women. Participants reported that community sensitization, availability of phone-based counseling, male clinic staff, extended clinic hours, and financial incentives could increase men’s HIVST use and linkage to care.

Conclusion

Participants expressed high interest in using HIVST, but secondary distribution was not universally preferred. We identified potential strategies to increase HIVST acceptability, particularly among PWHIV and those in unstable partnerships which can inform strategies to optimize HIVST distribution.

Introduction

Compared to women, men in sub-Saharan Africa (SSA) have suboptimal rates of HIV testing, resulting in delayed initiation of antiretroviral therapy (ART) and increased morbidity, mortality, and onward transmission [1]. In Uganda, approximately 1.4 million people were living with HIV in 2021, of whom 91% were aware of their status [2]. High ANC attendance in SSA (93% in Uganda) results in the majority of women receiving integrated HIV testing services during pregnancy [3]. However, men’s HIV testing rates remain low (73%) despite efforts to improve testing uptake (e.g. invitation letters for fast-track testing at ANC) [4].

HIV self-testing (HIVST) is shown to achieve high uptake among men in SSA and could increase men’s HIV testing and linkage to care [514]. A promising HIVST delivery strategy is secondary distribution, whereby pregnant women attending antenatal care (ANC) are given an HIVST kit to deliver to their male partners and are trained on its use and interpretation (Fig 1a) [15, 16]. Among pregnant women living with HIV (PWHIV), HIVST secondary distribution can promote couples testing and disclosure which can increase women’s retention in ART and prevention of mother-to-child transmission (PMTCT) programs [17]. Furthermore, testing partners of PWHIV can be a high yield strategy to identify men with HIV [18, 19].

Fig 1.

Fig 1

a. Standard cascade of HIVST secondary distribution. b. Re-envisioned cascade of HIVST distribution*. *PSG: peer support groups.

The World Health Organization (WHO) has recommended scale-up of secondary distribution of HIVST kits to pregnant women to give to their partners; several countries in SSA, including Uganda, have begun national rollout [20, 21]. Because HIVST is a screening test, Uganda Ministry of Health Guidelines encourage individuals who self-test positive to seek HIV clinical services for confirmatory testing and linkage to treatment depending on results [22]. Studies have shown high uptake of HIVST among men after secondary distribution. However, most studies relied on self-report from female partners and the vast majority of pregnant women were HIV-negative [6]. There are little qualitative data regarding women and men’s perspectives on implementation strategies to increase women’s HIVST distribution, and men’s testing uptake and clinic linkage. Further, there is a lack of data assessing perspectives of PWHIV who face unique barriers including fear of HIV status disclosure. Finally, the success of HIVST distribution is contingent on linkage to care among men who self-test HIV-positive; however, data are lacking on successful interventions to increase clinic linkage. We assessed pregnant women and male partners’ perspectives regarding HIVST acceptability, barriers, facilitators, and strategies to optimize HIVST secondary distribution and men’s clinic linkage.

Methods

Study design and participant recruitment

We conducted focus group discussions (FGDs) and in-depth interviews (IDIs) between 2019–2020. Pregnant women reporting not knowing their partner’s HIV status were recruited in person from two public ANC clinics in Kampala, Uganda. Additional women who were not invited to participate in FGDs and IDIs were asked to provide phone numbers for their partners. A male Ugandan qualitative researcher and qualified translator (JM) telephoned partners of consenting women to invite them to participate. Eligibility criteria for all participants were: ≥18 years and willing to provide informed consent. Eligibility criteria for women were: currently pregnant, in a relationship, not aware of their partner’s HIV status, not attending ANC with their partner, and low risk for intimate partner violence (IPV). Healthcare workers assessed women’s IPV risk following the World Health Organization’s standardized screening tool for clinical diagnosis of IPV [23]. Eligibility criteria for men were: having a pregnant partner attending ANC and having a working phone for contact purposes.

FGDs had 8–12 participants per group to include multiple perspectives on barriers and facilitators to HIVST uptake and clinic linkage [11, 24]. Separate FGDs were held for men and women; among women, FGDs were separated by HIV status, aside from one. We purposively sampled three FGDs consisting of only PWHIV to provide a safe space and understand how their perspectives differed from HIV-negative women. IDIs were conducted by JM alone with men and women not participating in FGDs to further explore personal narratives regarding HIV testing, HIVST delivery, and disclosure. Since HIVST secondary distribution was not part of standard ANC care at the time of data collection, participants were asked to speak hypothetically about their willingness to use HIVST.

Data collection and analysis

Semi-structured interview topics included HIV risk perception; gender norms; barriers and facilitators of facility HIV testing, secondary distribution of HIVST, couples testing and disclosure, and clinic linkage; and interventions to increase HIVST uptake and clinic linkage [24, 25]. FGDs and IDIs lasted approximately 90 minutes and were facilitated by a trained Ugandan qualitative researcher (JM), in discreet and convenient locations in the community, and audio-recorded. Participants were first asked about their awareness of HIVST and then provided a verbal explanation of HIVST before proceeding with remaining topics. Participants were reimbursed for time and transport (8 USD).

Recordings were transcribed verbatim and translated from Luganda to English by JM, and all personally identifiable information was removed. Data were then imported into NVivo 12 Software (QSR International, Burlington, MA) for data management and analysis. Transcripts were coded using NVivo and the coded data were analyzed by MB, BN, and MS; 20% of all FGD and IDIs were double-coded to resolve inter-coder discrepancies through team discussion and refinement of the final codebook. The coding tree intended to categorize barriers and facilitators of HIVST, and suggested strategies to encourage male uptake. Since we had a pre-defined research question, we elected to use a deductive approach based on codes and categories specified a priori. We used the socio-ecological model to organize key findings derived from the analysis [26] (Fig 2). This model comprises of interconnected “rings” that fit within each other: Individual, Relationship, Community, and Societal. We conducted deductive content analysis, creating a codebook guided by this framework and organizing transcripts into categories defined during coding [27]. Data from FGDs and IDIs were coded separately and combined during analysis for interpretation. Additional information about data collection and analysis, as well as a checklist of ethical, cultural, and scientific considerations regarding inclusivity in global research, can be found in the S1 File.

Fig 2. Socio-ecological model with barriers and facilitators.

Fig 2

Fig 2 summarizes the key themes discussed by participants, based on a socio-ecological model. Within each ring of the framework, common barriers for uptake of secondary distribution of HIVST are presented. Outside of the rings, common facilitators that could support or motivate uptake are presented; arrows point to barriers that the facilitators might be relevant for addressing.

Ethical approvals

This study was approved by the University of Washington (STUDY00006094), the Mildmay Uganda Research Ethics Committee (#REC REF 0112–2018) and the Uganda National Council for Science and Technology (HS391ES). Participants provided written informed consent.

Results

We conducted 14 FGDs (9 with men, 3 with PWHIV, one with HIV-negative pregnant women, and one with pregnant women of mixed HIV status) and 10 IDIs (5 with men and 5 with women), with a total of 122 participants (Table 1). The median age among men (N = 64) was 30 years (interquartile range [IQR] 22–54) and 27 years (IQR 19–41) among women (N = 58). Approximately 53% of women and 6.3% men self-reported having HIV. Most participants were cohabitating (87%) and another 11.5% were married. Women had higher median education than men (12th vs. 6th grade, respectively) and participants had a median of two children.

Table 1. Participant characteristics.

Overall (N = 122) Men (N = 64) Women (N = 58)
n (%) or median (IQR)
Self-reported HIV status
 HIV-positive 35 (28.7) 4 (6.3) 31 (53.5)
 HIV-negative 83 (68.0) 57 (89.0) 26 (44.8)
 Don’t know 4 (3.3) 3 (4.7) 1 (1.7)
Marital status
 Married 14 (11.5) 12 (18.7) 2 (3.45)
 Cohabitating 106 (86.9) 52 (81.3) 54 (93.1)
 Not living together 2 (1.6) 0 (0.00) 2 (3.45)
Has paid occupation 94 (77.0) 64 (100.0) 30 (51.7)
Median age (years) 28 (25–32) 30 (27–35) 27 (24–30)
Median number of children 2 (1–3) 2 (1–4) 1 (0–2)
Median level of education 10th grade (7–12) 6th grade (6–10) 12th grade (9–12)

Awareness and acceptability of HIVST and secondary distribution

Low awareness of HIVST

Most participants generally reported low awareness of HIVST; often stating that they “did not know HIV could be detected using saliva”. Some participants expressed reluctance to use a test they were not familiar with.

“I wouldn’t want to use it [HIVST kit] because I don’t understand it very well, I only know the option of removing blood from the finger.

Man, age 36 years, FGD

Perceived benefits of HIVST

Once participants received an explanation about HIVST, they reported high interest in using them, mentioning HIVST’s potential to overcome barriers of facility-based testing, including long travel distances, wait times, lost wages, and fear of needle pricks. Participants reported that using HIVST “can benefit the health of the whole family” including the unborn baby (Table I in S1 Appendix).

Both men and women mentioned HIVST could reach more men by overcoming concerns about confidentiality and stigma of couples- or clinic-based testing.

“HIV self-test is like a fishing net to trap men to test for HIV because men don’t want to come out openly and test … [HIVST] is used secretly and gives safety to men who are not brave enough to go with their partners to the hospital to test.

HIV-negative man, age 32, FGD

Acceptability of HIVST secondary distribution

Some men were supportive of secondary distribution stating that it would strengthen their relationship, since testing together “binds the two of you” (Table I in S1 Appendix). Women expressed interest in delivering HIVST kits to their partners, but only if they were in a strong relationship, characterized by “mutual understanding.” Women stressed the importance of receiving training from healthcare workers (HCWs) regarding HIVST use and interpretation, strategies to approach their partner so they can “handle him properly”, including how to answer questions about why they brought HIVST to their partner.

“You start to feel how to approach him, he may ask you, ‘Why did you bring me this kit? Don’t you trust me’? It needs bravery to take him the kit…the woman also needs to be counseled on how to handle the man so that he is likely to accept it.

HIV-negative woman, age 27, IDI

Barriers to HIVST and secondary distribution

Most HIV-negative men reported fearing HIV testing in general because an HIV-positive result “affects you worse” than continuing to live unaware of HIV infection. These men expressed a fatalism that HIV would mean impending death. Both men and women discussed that although men may cite lack of time or money to attend the clinic as barriers to testing, the main reason is “the fear inside them.” Many men reported reluctance to HIV self-test alone without counseling, particularly in the case of a positive result, stating that their “heart can burst” or they may harm themselves instead of going to the clinic for support. When asked about mobile phone counseling from HCWs, men stated that this would help them “stay strong” and “give hope” about linking to treatment. Meeting other men successfully living with HIV in the clinic was also described as a benefit of clinic-based testing.

A salient fear of secondary distribution was self-testing HIV-positive and disclosing to one’s partner (Table II in S1 Appendix). Both men and women expressed fears that testing HIV-positive would lead to blame for “bringing the virus into the relationship”. Therefore, participants hesitated to test in their partners’ presence. PWHIV in particular highlighted concerns about abandonment and loss of financial support for themselves, their baby and other children due to disclosure, stating that they are “not in a position to deliver the kit.

“Remember [I] am pregnant and HIV positive…after self-testing he abandons you in the house and remember it is a house for renting, you have to pay landlord, look for what to eat, there are items needed in the hospital but he left you in the house and you have nowhere to look for him.

HIV-positive woman, age 30, FGD

Participants commonly reported lacking confidence that adherence to ART and viral suppression can prevent HIV transmission between partners (i.e., “undetectable = untransmittable”, “U = U”), contributing to common beliefs that serodifferent partnerships could not stay together without transmitting the virus.

“Am not aware about [U = U]…and you cannot convince me that the woman who is taking her HIV medication regularly cannot transmit HIV to me and I should have unprotected sex with her or stay with her, I don’t believe it and I cannot tolerate it.

HIV-negative man, age 48, FGD

One man expressed that if he were diagnosed with HIV, his love for his partner would compel him to leave her to prevent spreading the virus to her and the unborn baby. Other participants reported that being in serodifferent relationships could mean staying together, but platonically, “living as brother and sister.” Some men shared experiences of staying in a serodifferent relationship, particularly with the use of HIV pre-exposure prophylaxis (PrEP).

“When I was tested positive, I realized that my wife is innocent… I disclosed to her and we went together [to test]… God answered my prayer for her to be negative… this helped me remain strong because I had suggested to separate with her but she insisted we stay together and the HCWs gave her drugs [PrEP] which prevent her from getting infected.

HIV-positive man, age 27, FGD

Many participants expressed concerns about IPV, suggesting that secondary distribution could lead to “quarrels,” “slaps”, and accusations of distrust. Several men and women stated that in relationships without “mutual respect and understanding,” HCWs should contact men directly and ask them to come to the facility to pick up HIVST kits instead of placing the responsibility on women to deliver kits.

In discussing gender norms, some men reported perceptions about lower intellectual capacity of women and their inability to explain HIVST use and results interpretation. Some men stated that they prefer a male HCW to call and counsel them about HIVST. Ultimately, participants agreed that a woman’s ability to deliver HIVST to her partner depends on their relationship dynamics.

“God created a man and woman where a man’s IQ is high compared to women and a man gives a listening ear to a fellow man …these women of ours, don’t know how to explain [HIVST] to us…so let it be your [HCW’s] responsibility.

HIV-positive man, age 27, FGD

Furthermore, some men expressed concerns about relying on their partner to interpret their results, fearing that she would learn his status before he does or may not tell him. They expressed reservations about sharing their HIV status with their female partners without knowing her status in return. Some participants suggested bringing home two HIVST kits would be beneficial so they can “self-test together and each come to know one’s status.”

“It is upon you [the HCW] to persuade her to bring two HIVST kits and we test together, because if she refuses to use it, I too won’t self-test. Instead I will give her excuses.

HIV-negative man, age 50, FGD

Suggested interventions for increasing men’s HIVST uptake and clinic linkage

Community sensitization

Most participants cited a lack of familiarity with HIVST as a barrier to their uptake. Many stressed the importance to increase awareness and confidence in one’s ability to use HIVST and interpret the results. Many participants suggested it is the responsibility of HCWs to provide community sensitization “deep in the villages” so that everyone can “gain confidence in its accuracy,” which would increase the likelihood of men accepting HIVST regardless of how they received it (e.g., partner, clinic, pharmacy, etc.).

Interventions to increase confirmatory testing and clinic linkage

Participants were asked to provide feedback about specific interventions based on the Socio-Ecological Model framework [28] (Fig 2). Participants agreed that having a male-only waiting room at the HIV clinic may increase clinic attendance, as “men feel small in a pool of women” (Table III in S1 Appendix). Some men also suggested having a male HCW call them beforehand and discreetly guide them through the clinic testing process, so they do not appear “lost”. Participants stated that frequent follow up calls from “vigilant HCWs” and meeting male peer guides living healthy lives with HIV would “give strength” and facilitate linkage to ART.

Most men cited barriers associated with poverty, including lack of funds to attend the clinic, inability to miss work (“a day without work is a day without food for my family”), and concerns about starting ART if found HIV-positive because they lack adequate nutrition (“no food in the belly to take ART with”). Furthermore, almost all men agreed that clinics should offer extended clinic hours during evenings and weekends so they could access services during less crowded times and without missing work. Men were also asked about financial incentives, fatherhood workshops, and employment training, and most agreed such offerings would motivate them to attend the clinic.

Perceptions of alternative HIVST distribution strategies

Almost all participants pointed to the need for multiple options to be available (Table IV in S1 Appendix). Some men preferred to receive kits directly from clinics to “ensure they are genuine”. Men’s opinions regarding pharmacy-based HIVST distribution were mixed, with some participants reporting that pharmacy pick-up was discreet and convenient, similar to obtaining pregnancy tests, while others expressed mistrust in pharmacy workers to maintain confidentiality or overcharge (“[pharmacists] are after your money”). Views on HIVST distribution from community health workers (CHWs) were largely negative, including concerns about confidentiality (i.e. “telling other community members that so and so was here and he tested HIV-positive”), and fear that CHWs will try to sell them HIVST kits at elevated prices. Some men preferred phone calls from male HCWs encouraging clinic HIV testing while others expressed interests in home visits from HCWs to provide counseling and testing.

“It is the responsibility of HCWs to get our numbers from our wives when they go for ANC services and persuade him to test, because if it was her who told me I am needed at the hospital, you would not have seen me here.

HIV-positive man, age 27, FGD

Re-envisioned cascade

Fig 1b summarizes participants’ suggested alternate strategies in a newly envisioned cascade model for secondary distribution of HIVST to improve male partner uptake.

Discussion

Overall, participants expressed high interest in using HIVST kits themselves, but secondary distribution was not universally preferred. While participants felt secondary distribution was acceptable for couples in relationships characterized by trust and mutual understanding, PWLHIV expressed concerns regarding discovering HIV serodifference, IPV, blame, and abandonment. Additionally, both men and women cited gender dynamics as a barrier of secondary distribution. Since Ugandan men are traditionally the breadwinners and heads of households, placing women in a position of educating men about a technology could result in relationship tension or refusal of HIVST because of lack of confidence in their partners’ ability to explain and interpret the test. Participants also expressed fear of testing HIV-positive without a counselor available to provide reassurance and encourage linkage to ART. Some men also expressed fear that testing HIV-positive in the presence of their partner would result in accusations of infidelity. These findings are consistent with previous studies assessing HIVST acceptability which highlight the importance of counseling availability to facilitate clinic linkage and disclosure [12, 13]. Our findings align with a recently completed randomized clinical trial in Uganda which evaluated secondary distribution of HIVST from PWHIV to their male partners and did not find an increase in men’s HIV testing in the intervention arm compared to standard of care arm of clinic testing [29].

Participants’ low awareness of HIVST resulted in lack of confidence in its accuracy and one’s self-ability to use and interpret the test. Community sensitization of both HIVST and secondary distribution are needed to increase familiarity and demand for HIVST, reduce the need for women to educate their partners, and alleviate tensions of challenging gender norms [14]. Education is also needed to instill confidence in the ability of oral HIVST to detect HIV antibodies in the mucosal fluid despite the virus itself not being present in saliva. At the time of data collection, secondary distribution of HIVST kits to pregnant women was just starting to be scaled up in Uganda, resulting in many participants learning about HIVST for the first time through this study. Participants reported low confidence in ART adherence to prevent transmission (“Undetectable = Untransmittable”), contributing to commonly expressed beliefs that serodifferent couples could not stay together without transmitting HIV. However, a few participants shared experiences of staying together despite serodifference with the help of counseling regarding U = U and/or PrEP. Community sensitization about the potential of ART to enable individuals to live full and healthy lives without transmitting HIV to their partners or unborn children could alleviate couples’ fears about HIVST while also addressing men’s fear of HIV testing in general. When offering secondary distribution of HIVST to pregnant women, midwives and counselors may need to provide additional counseling time for PWLHIV to successfully deliver HIVST to their partners, compared to pregnant women without HIV who do not face the same fears around disclosure and abandonment.

Our findings highlight opportunities to improve HIVST delivery. Providing men alternative avenues for obtaining HIVST can avoid the burden placed on pregnant women of being solely responsible for HIVST distribution, particularly for PWHIV, women at risk of IPV, or those in unstable partnerships. Pregnancy is a high-risk time for women in SSA since relationship dissolution could lead to economic vulnerability for themselves and their children. Additionally, pregnant women are at high risk of IPV and HIV acquisition, and PWHIV experiencing IPV are at higher risk of treatment non-adherence [30, 31]. According to the Ugandan Demographic and Health Survey, 39.6% of women ≥15 years had experienced physical, sexual, or psychological IPV within the last 12 months [32]. HIVST secondary distribution has not been evaluated in the context of high IPV risk and therefore may not currently be appropriate for women with IPV risk. We suggest a hybrid model (Fig 1b) which involves providing females the option of having male HCWs call their partners directly to offer the option of coming to the facility to obtain HIVST. Regardless of distribution strategy, participants expressed desire for phone-based or in person counseling from a male HCW after HIVST. Linkage strategies to promote men’s clinic attendance after HIVST are not well evaluated. When asked to provide feedback on specific interventions, men stated that separate “male friendly” waiting rooms, male guides at the clinic, and male “champions” (men living with HIV who counsel newly diagnosed men) may encourage clinic linkage. Lastly, extended clinic hours, financial incentives, and workshops could address the lack of time and money to miss work. Our findings align with previous studies which find that providing men with financial incentives can increase engagement with HIV services [33, 34]. Further research is needed on the potential of other suggested interventions to increase men’s linkage.

Our study has several limitations. Participants were purposefully sampled and may not represent the views of all pregnant women and male partners. We enrolled men whose female partners consented to provide their contact information, which may bias our sample towards those in stable partnerships. Few participants reported experience with HIVST secondary distribution, but most discussed their preferences hypothetically, which may not correlate with health behavior. The FGDs may be subject to social desirability bias. However, we stratified FGDs by gender and HIV status and conducted IDIs to further elicit participant views. Further, our qualitative interviewer was male; while this was likely a strength for obtaining male participant perspectives, it could have impacted women’s comfort in discussing sensitive topics such as HIV, sexual behavior, and gender roles.

Strengths of our study include recruiting men not accompanying their partners to ANC and oversampling PWHIV. Our findings differ from previous qualitative studies on HIVST secondary distribution which found high acceptability among participants [24, 35, 36]. One study recruited men who were attending ANC, who may be more likely to be in stable partnerships conducive to HIVST delivery [24]. Another study recruited pregnant women and male partners who successfully used HIVST, thus not capturing the perspectives of women who did not deliver HIVST and men who refused to self-test [35]. These studies do not capture barriers that prevented successful HIVST delivery or testing uptake. Additionally, men attending ANC may be more likely to undergo clinic HIV testing. Assessing perspectives of men not attending ANC with their partners provides important information on the potential of HIVST for men who do not test at the clinic. Finally, the third study did not purposively sample PWHIV [36], who experience distinct barriers and will require targeted counseling to enable successful delivery of HIVST and reduce risks of adverse events. Although we found high acceptability for collecting HIVST from clinics, perspectives on pharmacy and CHW-distribution were largely negative; participants described lacking trust in providers, concerns about confidentiality and counterfeit or over-priced tests. Our finding differs from previous studies showing high acceptability of pharmacy-based HIVST distribution in Kenya [37]. However, that study sampled participants who expressed interest in HIVST so may not be representative of population acceptability.

Conclusion

Overall, we find providing participants alternative avenues for HIVST distribution and options for counseling support may increase uptake among male partners of pregnant women in Uganda and similar settings. Future studies are needed to assess the potential of integrating tailored strategies into existing programs to safely expand HIV testing and clinic linkage among men.

Supporting information

S1 File

(PDF)

S1 Appendix. Additional quotes.

(DOCX)

Acknowledgments

We would like to thank the study team and the study participants. We gratefully acknowledge Dr. Karusa Kiragu, the Country Director of The Joint United Nations AIDS Program (UNAIDS) in Uganda, for providing her insight and expertise.

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

This study was funded by the U.S. National Institute of Mental Health (K01MH115789), awarded to Dr. Monisha Sharma. The funders had no role in study design, data collection, analysis, writing of the report, nor the decision to submit for publication.

References

  • 1.Musheke M, Ntalasha H, Gari S, McKenzie O, Bond V, Martin-Hilber A, et al. A systematic review of qualitative findings on factors enabling and deterring uptake of HIV testing in Sub-Saharan Africa. BMC public health. 2013;13:220. doi: 10.1186/1471-2458-13-220 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.UNAIDS. Uganda Data UNAIDS.org. Accessed on September 7, 20222021.
  • 3.UNICEF: Antenatal care coverage. http://data.unicef.org/topic/maternal-health/antenatal-care/ on 2/26/2017
  • 4.Mohlala BK, Boily MC, Gregson S. The forgotten half of the equation: randomized controlled trial of a male invitation to attend couple voluntary counselling and testing. AIDS (London, England). 2011;25(12):1535–41. doi: 10.1097/QAD.0b013e328348fb85 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Conroy A, Leddy A, Johnson M, et al., editors. “I told her this is your life”: how primary partners help overcome barriers related to ART adherence in South Africa. [Oral]. AIDS Conference 2016, Durban, South Africa; 2016.
  • 6.Thirumurthy H, Masters SH, Mavedzenge SN, et al. Promoting male partner HIV testing and safer sexual decision making through secondary distribution of self-tests by HIV-negative female sex workers and women receiving antenatal and post-partum care in Kenya: a cohort study. The Lancet HIV. 2016;3(6):266–74. doi: 10.1016/S2352-3018(16)00041-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Masters SH, Agot K, Obonyo B, et al. Promoting Partner Testing and Couples Testing through Secondary Distribution of HIV Self-Tests: A Randomized Clinical Trial. PLoS Med. 2016;13(11):e1002166. doi: 10.1371/journal.pmed.1002166 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Pintye J, Drake AL, Begnel E, et al. Acceptability and outcomes of distributing HIV self-tests for male partner testing in Kenyan maternal and child health and family planning clinics. AIDS. 2019;33(8):1369–1378. doi: 10.1097/QAD.0000000000002211 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Napierala S, Bair E, Marcus N, et al. Male partner testing and sexual behaviour following provision of multiple HIV self-tests to Kenyan women at higher risk of HIV infection in a cluster randomized trial. Journal of the International AIDS Society. 2020;23(S2):e25515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Gichangi A, Wambua J, Mutwiwa S, et al. Impact of HIV Self-Test Distribution to Male Partners of ANC Clients: Results of a Randomized Controlled Trial in Kenya [published correction appears in J Acquir Immune Defic Syndr. 2019 Oct 1;82(2):e42]. J Acquir Immune Defic Syndr. 2018;79(4):467–473. doi: 10.1097/QAI.0000000000001838 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Choko AT, Desmond N, Webb EL, Chavula K, Napierala-Mavedzenge S, Gaydos CA, et al. The uptake and accuracy of oral kits for HIV self-testing in high HIV prevalence setting: a cross-sectional feasibility study in Blantyre, Malawi. PLoS Med. 2011;8(10):e1001102. doi: 10.1371/journal.pmed.1001102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Njau B, Lisasi E, Damian DJ, et al. Feasibility of an HIV self-testing intervention: a formative qualitative study among individuals, community leaders, and HIV testing experts in northern Tanzania. BMC Public Health. 2020;20:490. doi: 10.1186/s12889-020-08651-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Njau B, Covin C, Lisasi E, et al. A systematic review of qualitative evidence on factors enabling and deterring uptake of HIV self-testing in Africa. BMC Public Health. 2019;19:1289. doi: 10.1186/s12889-019-7685-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.World Health Organization (WHO). Status of HIV self-testing in national policies. https://apps.who.int/iris/bitstream/handle/10665/326035/WHO-CDS-HIV-19.20-eng.pdf?ua=1 Accessed on May 3, 2022 2019
  • 15.Azuonwu O, Erhabor O, Frank-Peterside N. HIV infection in long-distance truck drivers in a low income setting in the Niger Delta of Nigeria. Journal of community health. 2011;36(4):583–7. doi: 10.1007/s10900-010-9344-4 [DOI] [PubMed] [Google Scholar]
  • 16.PHIA. Uganda Population-Based HIV Impact Assessment: UPHIA 2016–2017. https://phia.icap.columbia.edu/countries/uganda/; 2019.
  • 17.Aluisio A, Richardson BA, Bosire R, et al. Male antenatal attendance and HIV testing are associated with decreased infant HIV infection and increased HIV-free survival. J Acquir Immune Defic Syndr. 2011;56(1):76–82. doi: 10.1097/QAI.0b013e3181fdb4c4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Lugada E, Levin J, Abang B, Mermin J, Mugalanzi E, Namara G, et al. Comparison of home and clinic-based HIV testing among household members of persons taking antiretroviral therapy in Uganda: results from a randomized trial. Journal of acquired immune deficiency syndromes (1999). 2010;55(2):245–52. doi: 10.1097/QAI.0b013e3181e9e069 [DOI] [PubMed] [Google Scholar]
  • 19.Henley C, Forgwei G, Welty T, Golden M, Adimora A, Shields R, et al. Scale-up and case-finding effectiveness of an HIV partner services program in Cameroon: an innovative HIV prevention intervention for developing countries. Sexually transmitted diseases. 2013;40(12):909–14. doi: 10.1097/OLQ.0000000000000032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.World Health Organization (WHO). Status of HIV self-testing in national policies. https://www.who.int/hiv/topics/self-testing/en/. Accessed on August 20, 2020. 2019
  • 21.WHO. Policy Brief: WHO recommends HIV self-testing. 2016.
  • 22.Uganda Ministry of Health P. National HIV Testing Services Policy and Implementation Guidelines. Ministry of Health (4th Edition). Kampala, Uganda2016.
  • 23.World Health Organization (WHO). WHO recommendation on clinical diagnosis of intimate partner violence in pregnancy. Accessed on September 6, 2022. 2018.
  • 24.Choko AT, Kumwenda MK, Johnson CC, et al. Acceptability of woman-delivered HIV self-testing to the male partner, and additional interventions: a qualitative study of antenatal care participants in Malawi. J Int AIDS Soc. 2017;20(1):21610. doi: 10.7448/IAS.20.1.21610 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Indravudh PP, Sibanda EL, d’Elbee M, Kumwenda MK, Ringwald B, Maringwa G, et al. ’I will choose when to test, where I want to test’: investigating young people’s preferences for HIV self-testing in Malawi and Zimbabwe. AIDS (London, England). 2017;31 Suppl 3:S203–S12. doi: 10.1097/QAD.0000000000001516 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Centers for Disease Control and Prevention (CDC). The Social-Ecological Model: A Framework for Prevention 2021 [https://www.cdc.gov/violenceprevention/about/social-ecologicalmodel.html].
  • 27.Gale NK, Heath G, Cameron E, et al. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13(17). doi: 10.1186/1471-2288-13-117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Salihu HM, Wilson RE, King LM, et al. Socio-ecological Model as a Framework for Overcoming Barriers and Challenges in Randomized Control Trials in Minority and Underserved Communities. Int J MCH AIDS. 2015; 3(1):85–95. [PMC free article] [PubMed] [Google Scholar]
  • 29.Mujugira A SG, Nakyanzi A, et al.,. Partner Testing with HIV Self-Test Distribution by Ugandan Pregnant Women with HIV. Conference on Retroviruses and Opportunistic Infections (CROI) Virtual, February 20222022.
  • 30.Bernstein M, Phillips T, Zerbe A, et al. Intimate partner violence experienced by HIV-infected pregnant women in South Africa: a cross-sectional study. BMJ Open. 2016;6:e011999. doi: 10.1136/bmjopen-2016-011999 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Gichane MW, Moracco KE, Thirumurthy H, et al. Intimate partner violence and prevention of mother to child transmission of HIV: Evidence from Kinshasa, Democratic Republic of Congo. PLoS ONE. 2018;13(8):e0203471. doi: 10.1371/journal.pone.0203471 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Uganda Bureau of Statistics, Government of Uganda. Uganda Demographic and Health Survey (DHS) 2016 data. https://dhsprogram.com/pubs/pdf/FR333/FR333.pdf; 2018.
  • 33.Bassett IV, Wilson D, Taaffe J, Freedberg KA. Financial incentives to improve progression through the HIV treatment cascade. Curr Opin HIV AIDS. 2015;10(6):451–63. doi: 10.1097/COH.0000000000000196 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Choko AT, Corbett EL, Stallard N, et al. HIV self-testing alone or with additional interventions, including financial incentives, and linkage to care or prevention among male partners of antenatal care clinic attendees in Malawi: An adaptive multi-arm, multi-stage cluster randomised trial. PLOS Medicine. 2019;16(1):e1002719. doi: 10.1371/journal.pmed.1002719 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Matovu JKB, Kisa R, Buregyeya E, et al. ’If I had not taken it [HIVST kit] home, my husband would not have come to the facility to test for HIV’: HIV self-testing perceptions, delivery strategies, and post-test experiences among pregnant women and their male partners in Central Uganda. Global Health Action. 2018;11(1):1503784. doi: 10.1080/16549716.2018.1503784 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Matovu JK, Buregyeya E, Arinaitwe J, Wanyenze RK. …if you bring the kit home, you [can] get time and test together with your partner’: Pregnant women and male partners’ perceptions regarding female partner-delivered HIV self-testing in Uganda—A qualitative study. Int J STD AIDS. 2017;28(13):1341–1347. [DOI] [PubMed] [Google Scholar]
  • 37.Mugo PM, Micheni M, Shangala J, et al. Uptake and Acceptability of Oral HIV Self-Testing among Community Pharmacy Clients in Kenya: A Feasibility Study. PLoS ONE. 2017;12(1):e0170868. doi: 10.1371/journal.pone.0170868 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Joel Msafiri Francis

10 Aug 2022

PONE-D-22-17033Pregnant women and male partner perspectives of secondary distribution of HIV self-testing kits in Uganda: A qualitative studyPLOS ONE

Dear Dr. Bulterys,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Sep 24 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Joel Msafiri Francis, MD, MS, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met.  Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript.

3. Thank you for stating the following in your Competing Interests section:  

"NO authors have competing interests"

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state ""The authors have declared that no competing interests exist."", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now 

 This information should be included in your cover letter; we will change the online submission form on your behalf.

4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. 

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Pregnant women and male partner perspectives of secondary distribution of HIV self-testing kits in Uganda: A qualitative study.

Congratulations on your study and development of this manuscript for publication. A study of this nature potentially can add to the body of knowledge on strategies to increase uptake of HIV testing among men in SSA. Below I offer comments that could make the manuscript more improved and valuable.

GENERAL COMMENT:

Overall the study was well designed and implemented and the manuscript is well written.

However I have few comments below to improve the manuscript.

1. Abstract: I would like to suggest that the authors should be consistent in using the words:“ Facilitators vs. motivators”. These words are used interchangeable through out the manuscript. See line 62 on page 3, line 112 on pages 5, and line 122 on pages 6, etc.

2. Introduction: The following sentence mentions “…regarding HIVST acceptability, barriers….”. Did the authors also assessed ”Motivators/facilitators?. If yes, it is not mentioned. See line 96 page 5.

3. Data collection and analysis: Did JM conduct all the interviews alone? What about a note taker? See line 125 on page 6.

4. It seems JM (male interviewer) conducted interviews for women. Could this be a limitation for women to express themselves freely on such sensitive issues to a male interviewer compared to a female interviewer? Could authors clarify on this observation? See line 125 on page 6.

5. In principal translations should be done by a qualified translated. Does this imply that JM is a qualified Translator? Could authors clarify on this observation? See line 129 on page 6.

6. The authors should mention what was the role of using the NVivo software in this study. See line 130 on page 6.

7. The authors mentioned that all FGDs and IDIs were double-coded to assess inter-coder reliability. Could authors provide the results of the inter-coder reliability? See 131 on page 6.

8. The authors also mentioned that they used the Social ecological model to organize the research questions and findings. However, It was very difficult to follow how the authors operationalize their findings and what was presented in Figure II. I suggest that the authors should align their findings and what is presented in the current Figure II. An additional description accompanying the Figure II will be very beneficial to readers. See line 132 on page 6 and line 170 on page 9.

9. The authors reported that they used deductive thematic analysis. The authors should provide justification of using the deductive thematic analysis compared to inductive thematic analysis. See line 134 on page 6.

10. The authors did not mention whether FGDs and IDIs data were analyzed jointly or separately and combined later during interpretation.

11. The authors did not mention how they applied reflexivity and rigor in terms of trustworthness, dependability, credibility and transferability throughout the data analysis from data collection to interpretation of the findings.

12. Ethical approval: The authors should provide ethics clearance certificate ID for both Ethics committees. See line 137 on page 6.

13. Authors did not mention measures taken to protect confidentiality and anonymity in this study.

14. Results: It was unnecessary to present median & IQR in a qualitative study. Could authors clarify on this observation? See line 144 and 148 on page 7.

15. The following sentence….”did not know HIV could be detected using saliva”. I think using the word ‘saliva’ is not correct in the HIVST perspective. What is used is oral fluid from the mucosa of the mouth. I suggest this should be corrected. See line 176 on page 9.

16. The following quote: “ HIV self-test is like a fishing net…their partners to the hospital to test”. This quote does not support what is described above. Authors should justify the use of the quote or present a relevant quote. See lines 187-190 on page 10.

17. Conclusion: Is missing in the main manuscript but presented in the abstract. Authors should add their conclusion in the main manuscript.

18. Authors have mentioned among other interventions “ financial incentives”. Despite existing literature supporting this intervention, I was wondering if this would be sustainable in case of scaling-up to the general population.

19. One of the key barriers for uptake of HIVST is the high cost of buying the HIV self-test kits. I was wondering if the authors assessed this common barrier.

Reviewer #2: Comments to the Author

Summary: Overall these study findings add very little evidence on secondary distribution of HIVST kits in an ante natal setting. I would recommend that the authors made major revisions. These include contexualising how their findings are different from other studies conducted in other countries in Africa.

Detailed comments are below.

Abstract:

1. Specify with whom FGDs and IDI’s were conducted (men, women etc)

Introduction:

1. I recommend providing stats on HIV testing in Uganda.

2. Briefly describe what testing is like among men and women.

3. Need to specify what the current status of HIVST in Uganda from a policy perspective.

4. The last paragraph is not clear what you are trying to establish. Many studies have already been done on acceptability and barriers. Many conducted on secondary distribution within ANC care. How is yours different?

Methods:

1. How was low risk for IPV established?

2. How many FGDs, how many IDI’s.

3. There are a lot of elements from the Consolidated Criteria for Reporting Qualitative Studies (COREQ) missing from the methods (https://academic.oup.com/intqhc/article/19/6/349/1791966). I strongly encourage the authors to consult the COREQ criteria and ensure that elements are covered

4. For each ‘finding’ (new paragraph), it would be preferable to provide some sense of how common it was, and among whom (women, men,). Doesn’t have to be as specific as the “Most (85%)…” under the first finding (although that level of specificity is helpful there). This will give a better sense, at the end, for a sort of pros/cons assessment which is currently missing – high acceptability and perceived effectiveness, and low concerns? Or more equal levels of both?

Results:

1. Information in first paragraph should be in the methods section

2. Where the men and women interviews also held by status? Refer to 2-3 line of first paragraph under methods.

3. Under “low awareness of HIVST”, there is mention of saliva. Context needs to be provided in the introduction and discussion of HIVST in Uganda, including tests used.

Discussion:

1. Results are comparative of other studies. How is this study different?

2. Most of the discussion summarises the results. Doesn’t offer much in terms of the strategies identified could be integrated.

3. To posit this work as a formative qualitative study, more information is needed to contextualize why this study was specifically needed, how it informed intervention development, and how the newly formed intervention would be subsequently used. qualitative study.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Angela Tembo

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Reviewers comment_PLOSONE.pdf

PLoS One. 2023 Feb 14;18(2):e0279781. doi: 10.1371/journal.pone.0279781.r002

Author response to Decision Letter 0


17 Oct 2022

Thank you for the opportunity to revise and resubmit our manuscript. Our responses to reviewer comments are attached.

Decision Letter 1

Joel Msafiri Francis

14 Dec 2022

Pregnant women and male partner perspectives of secondary distribution of HIV self-testing kits in Uganda: A qualitative study

PONE-D-22-17033R1

Dear Dr. Bulterys,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Joel Msafiri Francis, MD, MS, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I am pleased that the authors have addressed all comments that I suggested and the manuscript can be accepted for publication.

Reviewer #2: Dear Editor,

The authors have adequately addressed the comments. The paper is now of publishable standard. I would however recommend that the authors consider repositioning the “re-envisioned cascade” to recommendations section.

Thank you

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Angela Tembo

**********

Acceptance letter

Joel Msafiri Francis

2 Feb 2023

PONE-D-22-17033R1

Pregnant women and male partner perspectives of secondary distribution of HIV self-testing kits in Uganda: A qualitative study

Dear Dr. Bulterys:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Joel Msafiri Francis

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File

    (PDF)

    S1 Appendix. Additional quotes.

    (DOCX)

    Attachment

    Submitted filename: Reviewers comment_PLOSONE.pdf

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES